Evidence map›Paper›PMID 39040016›Full record

ArticleACR open rheumatology2024

Prediction of Early Adverse Events After THA: A Comparison of Different Machine-Learning Strategies Based on 262,356 Observations From the Nordic Arthroplasty Register Association (NARA) Dataset.

Mikko S Venäläinen, Valtteri J Panula, Antti P Eskelinen, Anne Marie Fenstad, Ove Furnes, Geir Hallan, Ola Rolfson, Johan Kärrholm, Nils P Hailer, Alma B Pedersen and 3 more

Abstract read
In one paragraph

Article in ACR open rheumatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mikko S VenäläinenTurku University Hospital, University of Turku and Åbo Akademi University, Turku, Finland.ORCID https://orcid.org/0000-0003-1777-4259
Valtteri J PanulaTurku University Hospital and University of Turku, Turku, Finland.ORCID https://orcid.org/0000-0001-6638-3188
Antti P EskelinenCoxa Hospital for Joint Replacement and University of Tampere, Tampere, Finland, and the Finnish Arthroplasty Register, Finnish Institute for Health and Welfare, Helsinki, Finland.ORCID https://orcid.org/0000-0003-0302-0253
Anne Marie FenstadHaukeland University Hospital, Bergen, Norway.ORCID https://orcid.org/0000-0002-6429-0153
Ove FurnesHaukeland University Hospital and University of Bergen, Bergen, Norway.ORCID https://orcid.org/0000-0001-8223-2515
Geir HallanHaukeland University Hospital and University of Bergen, Bergen, Norway.ORCID https://orcid.org/0000-0002-8202-3462
Ola RolfsonUniversity of Gothenburg, Gothenburg, Sweden.ORCID https://orcid.org/0000-0001-6534-1242
Johan KärrholmUniversity of Gothenburg, Gothenburg, Sweden.ORCID https://orcid.org/0000-0003-4782-7999
Nils P HailerUppsala University Hospital, Uppsala, Sweden.ORCID https://orcid.org/0000-0002-3233-2638
Alma B PedersenAarhus University Hospital and Aarhus University, Aarhus, Denmark.ORCID https://orcid.org/0000-0002-3288-9401
Søren OvergaardCopenhagen University Hospital and University of Copenhagen, Copenhagen, Denmark.ORCID https://orcid.org/0000-0001-6829-4787
Keijo T MäkeläTurku University Hospital and University of Turku, Turku, Finland, and the Finnish Arthroplasty Register, Finnish Institute for Health and Welfare, Helsinki, Finland.ORCID https://orcid.org/0000-0002-4115-1767
Laura L EloUniversity of Turku and Åbo Akademi University, Turku, Finland.ORCID https://orcid.org/0000-0001-5648-4532

Funding

European Research Council 677943European Union's Horizon 2020 research and innovation programme 955321Research Council of Finland 310561Research Council of Finland 314443Research Council of Finland 322123Research Council of Finland 329278Research Council of Finland 335434Research Council of Finland 335611Research Council of Finland 341342Swedish Research Council VR 2021-00980
6 · The paper itself

Abstract

objectivePreoperative risk prediction models can support shared decision-making before total hip arthroplasties (THAs). Here, we compare different machine-learning (ML) approaches to predict the six-month risk of adverse events following primary THA to obtain accurate yet simple-to-use risk prediction models.

methodsWe extracted data on primary THAs (N = 262,356) between 2010 and 2018 from the Nordic Arthroplasty Register Association dataset. We benchmarked a variety of ML algorithms in terms of the area under the receiver operating characteristic curve (AUROC) for predicting the risk of revision caused by periprosthetic joint infection (PJI), dislocation or periprosthetic fracture (PPF), and death. All models were internally validated against a randomly selected test cohort (one-third of the data) that was not used for training the models.

resultsThe incidences of revisions because of PJI, dislocation, and PPF were 0.8%, 0.4%, and 0.3%, respectively, and the incidence of death was 1.2%. Overall, Lasso regression with stable iterative variable selection (SIVS) produced models using only four to five input variables but with AUROC comparable to more complex models using all 32 variables available. The SIVS-based Lasso models based on age, sex, preoperative diagnosis, bearing couple, fixation, and surgical approach predicted the risk of revisions caused by PJI, dislocations, and PPF, as well as death, with AUROCs of 0.61, 0.67, 0.76, and 0.86, respectively.

conclusionOur study demonstrates that satisfactory predictive potential for adverse events following THA can be reached with parsimonious modeling strategies. The SIVS-based Lasso models may serve as simple-to-use tools for clinical risk assessment in the future.

Identifiers

PMID39040016
PMCPMC11471944

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.